loading page

Pediatric Cancer Research: Surviving COVID-19
  • +9
  • Jeffery Auletta,
  • Peter Adamson,
  • Jonathan Agin,
  • Pamela Kearns,
  • Scott Kennedy,
  • Mark Kieran ,
  • Donna Ludwinski,
  • Leona Knox,
  • Kristi McKay,
  • Pia Rhiner,
  • Carol Thiele,
  • Timothy Cripe
Jeffery Auletta
Nationwide Children's Hospital

Corresponding Author:[email protected]

Author Profile
Peter Adamson
Sanofi Genzyme
Author Profile
Jonathan Agin
MaxCure
Author Profile
Pamela Kearns
University of Birmingham Institute of Cancer and Genomic Sciences
Author Profile
Scott Kennedy
Solving Kids' Cancer
Author Profile
Mark Kieran
Dana-Farber Boston Children’s Hospital
Author Profile
Donna Ludwinski
Solving Kids' Cancer
Author Profile
Leona Knox
Solving Kids' Cancer
Author Profile
Kristi McKay
Solving Kids' Cancer
Author Profile
Pia Rhiner
Solving Kids' Cancer
Author Profile
Carol Thiele
National Cancer Instititute
Author Profile
Timothy Cripe
Nationwide Children's
Author Profile

Abstract

A diverse panel of pediatric cancer advocates and experts, whose collective experience spans the continuum of international academic medicine, industry, federal research, and cancer advocacy, recently discussed challenges for pediatric cancer research in the context of Coronavirus Disease 2019 (COVID-19). Specifically, this special report addresses the following focus areas: (1) the critical role that translational research has played in transforming pediatric cancer outcomes; (2) the current and potential future impact of COVID-19 on pediatric cancer research; (3) target areas of COVID-19 research that may have application in immunity, oncogenesis and therapeutic discovery; and (4) future considerations and directions in maintaining pediatric cancer research during and after COVID-19.
06 May 2020Submitted to Pediatric Blood & Cancer
06 May 2020Submission Checks Completed
06 May 2020Assigned to Editor
07 May 2020Review(s) Completed, Editorial Evaluation Pending
07 May 2020Editorial Decision: Accept
Sep 2020Published in Pediatric Blood & Cancer volume 67 issue 9. 10.1002/pbc.28435